GX-188E vaccination

GX-188E · Genexine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GX-188E vaccination, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer [Phase 1, Phase 2]

See pricing